X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3137) 3137
invasive candidiasis (1814) 1814
antifungal agents - therapeutic use (1431) 1431
infectious diseases (1368) 1368
male (1362) 1362
female (1347) 1347
microbiology (1327) 1327
epidemiology (991) 991
candidiasis (929) 929
middle aged (927) 927
adult (912) 912
fluconazole (827) 827
mycoses (809) 809
pharmacology & pharmacy (775) 775
antifungal agents (766) 766
candidemia (730) 730
mycology (713) 713
aged (712) 712
invasive fungal-infections (695) 695
risk factors (690) 690
mortality (656) 656
risk-factors (637) 637
aspergillosis (634) 634
diagnosis (628) 628
infections (625) 625
candida (621) 621
antifungal agents - pharmacology (617) 617
invasive aspergillosis (610) 610
amphotericin-b (603) 603
health aspects (593) 593
candidiasis - drug therapy (559) 559
immunology (559) 559
fungal-infections (524) 524
animals (503) 503
fungal infections (487) 487
adolescent (475) 475
candida - isolation & purification (465) 465
blood-stream infections (464) 464
liposomal amphotericin-b (457) 457
caspofungin (455) 455
retrospective studies (442) 442
voriconazole (441) 441
microbial sensitivity tests (439) 439
antifungal agents - administration & dosage (436) 436
candidiasis - microbiology (432) 432
treatment outcome (432) 432
child (424) 424
candida - drug effects (409) 409
mycoses - drug therapy (409) 409
transplantation (385) 385
management (379) 379
echinocandins (374) 374
infection (365) 365
pediatrics (360) 360
therapy (347) 347
young adult (342) 342
prophylaxis (339) 339
echinocandins - therapeutic use (336) 336
intensive-care-unit (331) 331
fungi (329) 329
candidiasis, invasive - drug therapy (327) 327
research (327) 327
care and treatment (319) 319
hematology (315) 315
micafungin (312) 312
aged, 80 and over (307) 307
antifungal agents - adverse effects (306) 306
analysis (301) 301
infant (301) 301
infant, newborn (301) 301
candidiasis - diagnosis (296) 296
immunocompromised host (295) 295
cancer (286) 286
drug resistance, fungal (282) 282
antifungal therapy (281) 281
invasive fungal infection (279) 279
candida albicans (277) 277
pharmacokinetics (277) 277
child, preschool (275) 275
medicine & public health (275) 275
amphotericin b (274) 274
candida - classification (264) 264
critically-ill patients (264) 264
aspergillosis - drug therapy (263) 263
internal medicine (262) 262
prospective studies (260) 260
neutropenia (258) 258
double-blind (257) 257
albicans (255) 255
incidence (254) 254
aspergillus (253) 253
mice (247) 247
neutropenic patients (246) 246
antifungal agents - pharmacokinetics (245) 245
patients (244) 244
invasive pulmonary aspergillosis (243) 243
dermatology (235) 235
intensive care units (235) 235
susceptibility (235) 235
mycoses - prevention & control (231) 231
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4454) 4454
Spanish (195) 195
German (126) 126
French (85) 85
Portuguese (28) 28
Russian (14) 14
Japanese (13) 13
Turkish (13) 13
Czech (7) 7
Estonian (7) 7
Polish (6) 6
Chinese (3) 3
Slovak (3) 3
Hungarian (2) 2
Indonesian (2) 2
Italian (2) 2
Korean (2) 2
Belarusian (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Seminars in Respiratory and Critical Care Medicine, ISSN 1069-3424, 02/2020, Volume 41, Issue 1, pp. 003 - 012
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2016, Volume 374, Issue 8, pp. 793 - 795
To the Editor: In their review on invasive candidiasis, Kullberg and Arendrup (Oct. 8 issue) 1 raise the question of what is the most appropriate initial... 
MEDICINE, GENERAL & INTERNAL | Candidiasis, Invasive | Humans | Antifungal Agents - therapeutic use | Echinocandins | Azoles | Candidiasis | Fluconazole | Triazoles | Species
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 7, p. e101510
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 10/2014, Volume 40, Issue 10, pp. 1429 - 1448
...) in critically ill patients. Unfortunately, the literature reflects intense confusion about the pathophysiology of invasive candidiasis and specific associated risk... 
Candida albicans | Pediatrics | Emergency Medicine | Invasive candidiasis | Intensive / Critical Care Medicine | Colonization index | Pain Medicine | Pneumology/Respiratory System | Medicine & Public Health | Empirical treatment | Anesthesiology | Candidemia | Nosocomial infections | Colonization | BLOOD-STREAM INFECTION | RANDOMIZED-CLINICAL-TRIAL | FLUCONAZOLE PROPHYLAXIS | ICU PATIENTS | INTENSIVE-CARE-UNIT | HIGH-RISK | ORAL NYSTATIN PROPHYLAXIS | PLACEBO-CONTROLLED TRIAL | INTRAABDOMINAL CANDIDIASIS | CRITICAL CARE MEDICINE | Candidiasis - transmission | Candidiasis - physiopathology | Candidiasis, Invasive - epidemiology | Cross Infection - prevention & control | Chemoprevention | Humans | Risk Factors | Candidiasis - epidemiology | Critical Illness | Intensive Care Units - statistics & numerical data | Candida albicans - growth & development | Candidiasis, Invasive - transmission | Cross Infection - transmission | Candidiasis - prevention & control | Candida albicans - drug effects | Candida albicans - isolation & purification | Cross Infection - microbiology | Candidiasis, Invasive - prevention & control | Immunocompromised Host | Candidiasis, Invasive - physiopathology | Antifungal Agents - administration & dosage | Cross Infection - epidemiology | Candidiasis | Physiological aspects | Causes of | Development and progression | Research | Diagnosis | Biological markers | My Paper 20 Years Later
Journal Article
Therapeutics and clinical risk management, ISSN 1178-203X, 2014, Volume 10, Issue 1, pp. 95 - 105
Journal Article
Journal Article
Journal Article